Stock CMG PHARMACEUTICAL CO LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company CMG Pharmaceutical Co Ltd Korea S.E.

Equities

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
- - Intraday chart for CMG Pharmaceutical Co Ltd
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI

Business Summary

CMG Pharmaceutical Co., Ltd is a Korea-based company specialized in the manufacture of pharmaceuticals. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. It is also engaged in the manufacture of stone products. The Company mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Restriction
98.8 %
- - 92,743 98.8 % -
Other
1.2 %
- - 1,164 1.2 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
98.2 %
81,756 99.5 % 92,176 98.2 % +12.75%
Asia
1.8 %
-- 1,646 1.8 % -
International (Other)
0.1 %
14 0.0 % 85 0.1 % +497.05%

Managers

Managers TitleAgeSince
Ju-Hyung Lee CEO
 Chief Executive Officer 62 05/11/15
Sang-Ki Kim BRD
 Director/Board Member 62 26/04/15
In-Chul Jung IRC
 Investor Relations Contact 53 -
Se-Won Lee AUD
 Comptroller/Controller/Auditor 79 29/03/15
Hyo-Mook Cho SAM
 Sales & Marketing 66 -

Members of the board

Members of the board TitleAgeSince
Ju-Hyung Lee CEO
 Chief Executive Officer 62 05/11/15
Sang-Ki Kim BRD
 Director/Board Member 62 26/04/15
Seung-Chul Han BRD
 Director/Board Member 61 -
Yoon-Sang Park BRD
 Director/Board Member 64 -
Jong-Hwa Park BRD
 Director/Board Member 69 -
Jong-Hyun Park BRD
 Director/Board Member 60 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 138,892,244 102,997,131 ( 74.16 %) 0 74.16 %

Shareholders

NameEquities%Valuation
CHABIOTECH CO.,LTD.
25.84 %
35,886,553 25.84 % 55 M
Mirae Asset Global Investments Co., Ltd.
0.0359 %
49,906 0.0359 % 76 370
Dimensional Fund Advisors Ltd.
0.0121 %
16,820 0.0121 % 25 739
DFA Australia Ltd.
0.005666 %
7,869 0.005666 % 12 042

Company contact information

CMG Pharmaceutical Co., Ltd.

14 Dosan-daero 66-gil Gangnam-gu

06064, Seoul

+

http://www.cmgpharma.co.kr
address CMG Pharmaceutical Co Ltd

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+15.91% 41.97B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.40% 22.34B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.48% 15.25B
CIPLA LIMITED Stock Cipla Limited
+16.12% 14B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.12% 12.06B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.58% 6.8B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.18% 5.49B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A058820 Stock
  4. Stock
  5. Company CMG Pharmaceutical Co Ltd